Listed

Orthofix Medical Inc.

OFIXNasdaqCIK 884624HealthcareFiscal year ends Dec 23

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$210.9m, Q2 FY2026
Operating income−$8.1m, Q2 FY2026
Net income−$15.8m, Q2 FY2026
Orthofix Medical Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m184Revenue, Q3 FY2023, three months to 2023-09-30$184.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure200Revenue, Q4 FY2023, three months to 2023-12-31$200.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure189Revenue, Q1 FY2024, three months to 2024-03-31$188.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure199Revenue, Q2 FY2024, three months to 2024-06-30$198.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure197Revenue, Q3 FY2024, three months to 2024-09-30$196.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure216Revenue, Q4 FY2024, three months to 2024-12-31$215.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure194Revenue, Q1 FY2025, three months to 2025-03-31$193.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure203Revenue, Q2 FY2025, three months to 2025-06-30$203.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure206Revenue, Q3 FY2025, three months to 2025-09-30$205.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure220Revenue, Q4 FY2025, three months to 2025-12-31$219.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure197Revenue, Q1 FY2026, three months to 2026-03-31$196.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure211Revenue, Q2 FY2026, three months to 2026-06-30$210.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Cost of revenue$m64.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$64.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure63.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$63.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure61.4Cost of revenue, Q1 FY2024, three months to 2024-03-31$61.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure63.9Cost of revenue, Q2 FY2024, three months to 2024-06-30$63.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure61.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$61.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure66.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$66.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure72.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$72.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure63.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$63.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure57.1Cost of revenue, Q3 FY2025, three months to 2025-09-30$57.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure63.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$63.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure57.2Cost of revenue, Q1 FY2026, three months to 2026-03-31$57.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure61.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$61.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Gross profit$m120Gross profit, Q3 FY2023, three months to 2023-09-30$119.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure137Gross profit, Q4 FY2023, three months to 2023-12-31$136.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure127Gross profit, Q1 FY2024, three months to 2024-03-31$127.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure135Gross profit, Q2 FY2024, three months to 2024-06-30$134.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure135Gross profit, Q3 FY2024, three months to 2024-09-30$135.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure149Gross profit, Q4 FY2024, three months to 2024-12-31$148.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure122Gross profit, Q1 FY2025, three months to 2025-03-31$121.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure140Gross profit, Q2 FY2025, three months to 2025-06-30$139.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure149Gross profit, Q3 FY2025, three months to 2025-09-30$148.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure156Gross profit, Q4 FY2025, three months to 2025-12-31$156.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure140Gross profit, Q1 FY2026, three months to 2026-03-31$139.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure150Gross profit, Q2 FY2026, three months to 2026-06-30$149.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Research and development$m18.6Research and development, Q3 FY2023, three months to 2023-09-30$18.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure18.9Research and development, Q4 FY2023, three months to 2023-12-31$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure19.5Research and development, Q1 FY2024, three months to 2024-03-31$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure18.0Research and development, Q2 FY2024, three months to 2024-06-30$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure17.3Research and development, Q3 FY2024, three months to 2024-09-30$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure18.8Research and development, Q4 FY2024, three months to 2024-12-31$18.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure19.8Research and development, Q1 FY2025, three months to 2025-03-31$19.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure15.9Research and development, Q2 FY2025, three months to 2025-06-30$15.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure14.8Research and development, Q3 FY2025, three months to 2025-09-30$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure15.4Research and development, Q4 FY2025, three months to 2025-12-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure15.3Research and development, Q1 FY2026, three months to 2026-03-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure15.9Research and development, Q2 FY2026, three months to 2026-06-30$15.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Selling, general and administrative$mnot reportednot reported132Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$131.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure134Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$134.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure130Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$130.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure136Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$136.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure133Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$133.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure136Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$136.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure148Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$148.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure137Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$136.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure135Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$134.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure138Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$138.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Operating income$m(24.4)Operating income, Q3 FY2023, three months to 2023-09-30−$24.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure(18.3)Operating income, Q4 FY2023, three months to 2023-12-31−$18.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(29.3)Operating income, Q1 FY2024, three months to 2024-03-31−$29.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure(24.9)Operating income, Q2 FY2024, three months to 2024-06-30−$24.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure(18.9)Operating income, Q3 FY2024, three months to 2024-09-30−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure(11.5)Operating income, Q4 FY2024, three months to 2024-12-31−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(48.9)Operating income, Q1 FY2025, three months to 2025-03-31−$48.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(16.0)Operating income, Q2 FY2025, three months to 2025-06-30−$16.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure(17.0)Operating income, Q3 FY2025, three months to 2025-09-30−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure0.5Operating income, Q4 FY2025, three months to 2025-12-31$494.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating income, Q1 FY2026, three months to 2026-03-31−$14.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(8.1)Operating income, Q2 FY2026, three months to 2026-06-30−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m0.5Income tax, Q3 FY2023, three months to 2023-09-30$472.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$125.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure0.9Income tax, Q1 FY2024, three months to 2024-03-31$851.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure1.1Income tax, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure0.8Income tax, Q3 FY2024, three months to 2024-09-30$751.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure(0.6)Income tax, Q4 FY2024, three months to 2024-12-31−$564.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure1.0Income tax, Q1 FY2025, three months to 2025-03-31$961.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(0.1)Income tax, Q2 FY2025, three months to 2025-06-30−$142.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure0.5Income tax, Q3 FY2025, three months to 2025-09-30$533.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$30.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-03-31$74.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure0.8Income tax, Q2 FY2026, three months to 2026-06-30$801.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Net income$m(28.9)Net income, Q3 FY2023, three months to 2023-09-30−$28.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure(22.2)Net income, Q4 FY2023, three months to 2023-12-31−$22.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(36.0)Net income, Q1 FY2024, three months to 2024-03-31−$36.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure(33.4)Net income, Q2 FY2024, three months to 2024-06-30−$33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure(27.4)Net income, Q3 FY2024, three months to 2024-09-30−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure(29.1)Net income, Q4 FY2024, three months to 2024-12-31−$29.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(53.1)Net income, Q1 FY2025, three months to 2025-03-31−$53.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure(14.1)Net income, Q2 FY2025, three months to 2025-06-30−$14.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure(22.8)Net income, Q3 FY2025, three months to 2025-09-30−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure(2.2)Net income, Q4 FY2025, three months to 2025-12-31−$2.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(20.9)Net income, Q1 FY2026, three months to 2026-03-31−$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure(15.8)Net income, Q2 FY2026, three months to 2026-06-30−$15.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Diluted EPS$ per share(0.77)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figurenot reported(0.95)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure(0.88)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure(0.71)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figurenot reported(1.35)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(0.36)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure(0.57)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figurenot reported(0.52)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(0.39)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Basic EPS$ per share(0.77)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.77 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figurenot reported(0.95)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure(0.88)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure(0.71)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.71 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figurenot reported(1.35)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(0.36)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure(0.57)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figurenot reported(0.52)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(0.39)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure

Balance sheet

Cash and equivalents$103.8m, Q2 FY2026
Long-term debt$221.6m, Q2 FY2026
Shareholders' equity$429.2m, Q2 FY2026
Orthofix Medical Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m33.7Cash and equivalents, Q3 FY2023, at 2023-09-30$33.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure33.1Cash and equivalents, FY2023, at 2023-12-31$33.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure27.0Cash and equivalents, Q1 FY2024, at 2024-03-31$27.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure26.4Cash and equivalents, Q2 FY2024, at 2024-06-30$26.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure30.1Cash and equivalents, Q3 FY2024, at 2024-09-30$30.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure83.2Cash and equivalents, FY2024, at 2024-12-31$83.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure58.0Cash and equivalents, Q1 FY2025, at 2025-03-31$58.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure65.6Cash and equivalents, Q2 FY2025, at 2025-06-30$65.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure62.9Cash and equivalents, Q3 FY2025, at 2025-09-30$62.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure82.0Cash and equivalents, FY2025, at 2025-12-31$82.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure120Cash and equivalents, Q1 FY2026, at 2026-03-31$120.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure104Cash and equivalents, Q2 FY2026, at 2026-06-30$103.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Current assets$m394Current assets, Q3 FY2023, at 2023-09-30$393.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061148.Report this figure420Current assets, FY2023, at 2023-12-31$420.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026066.Report this figure399Current assets, Q1 FY2024, at 2024-03-31$399.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure386Current assets, Q2 FY2024, at 2024-06-30$386.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure386Current assets, Q3 FY2024, at 2024-09-30$386.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure433Current assets, FY2024, at 2024-12-31$433.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure390Current assets, Q1 FY2025, at 2025-03-31$390.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure396Current assets, Q2 FY2025, at 2025-06-30$395.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure394Current assets, Q3 FY2025, at 2025-09-30$394.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure417Current assets, FY2025, at 2025-12-31$416.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure462Current assets, Q1 FY2026, at 2026-03-31$461.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure446Current assets, Q2 FY2026, at 2026-06-30$446.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Total assets$m906Total assets, Q3 FY2023, at 2023-09-30$905.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0000950170-23-061148.Report this figure925Total assets, FY2023, at 2023-12-31$925.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-25, accession 0000950170-25-026066.Report this figure906Total assets, Q1 FY2024, at 2024-03-31$906.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure882Total assets, Q2 FY2024, at 2024-06-30$882.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure868Total assets, Q3 FY2024, at 2024-09-30$867.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure893Total assets, FY2024, at 2024-12-31$893.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure823Total assets, Q1 FY2025, at 2025-03-31$823.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure837Total assets, Q2 FY2025, at 2025-06-30$837.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure833Total assets, Q3 FY2025, at 2025-09-30$832.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure851Total assets, FY2025, at 2025-12-31$850.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure887Total assets, Q1 FY2026, at 2026-03-31$886.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure873Total assets, Q2 FY2026, at 2026-06-30$873.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Current liabilities$m153Current liabilities, Q3 FY2023, at 2023-09-30$152.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061148.Report this figure165Current liabilities, FY2023, at 2023-12-31$165.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026066.Report this figure151Current liabilities, Q1 FY2024, at 2024-03-31$150.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure156Current liabilities, Q2 FY2024, at 2024-06-30$156.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure162Current liabilities, Q3 FY2024, at 2024-09-30$161.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure169Current liabilities, FY2024, at 2024-12-31$168.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure144Current liabilities, Q1 FY2025, at 2025-03-31$144.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure148Current liabilities, Q2 FY2025, at 2025-06-30$148.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure160Current liabilities, Q3 FY2025, at 2025-09-30$159.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure170Current liabilities, FY2025, at 2025-12-31$170.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure161Current liabilities, Q1 FY2026, at 2026-03-31$161.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure157Current liabilities, Q2 FY2026, at 2026-06-30$157.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Total liabilities$m290Total liabilities, Q3 FY2023, at 2023-09-30$290.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0000950170-23-061148.Report this figure327Total liabilities, FY2023, at 2023-12-31$326.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0000950170-25-026066.Report this figure336Total liabilities, Q1 FY2024, at 2024-03-31$335.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure336Total liabilities, Q2 FY2024, at 2024-06-30$336.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure342Total liabilities, Q3 FY2024, at 2024-09-30$341.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure390Total liabilities, FY2024, at 2024-12-31$390.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure365Total liabilities, Q1 FY2025, at 2025-03-31$364.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure379Total liabilities, Q2 FY2025, at 2025-06-30$378.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure390Total liabilities, Q3 FY2025, at 2025-09-30$390.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure401Total liabilities, FY2025, at 2025-12-31$400.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure451Total liabilities, Q1 FY2026, at 2026-03-31$451.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure444Total liabilities, Q2 FY2026, at 2026-06-30$443.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Long-term debt$m70.0Long-term debt, Q3 FY2023, at 2023-09-30$70.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0000950170-23-061148.Report this figure93.1Long-term debt, FY2023, at 2023-12-31$93.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-02-25, accession 0000950170-25-026066.Report this figure115Long-term debt, Q1 FY2024, at 2024-03-31$115.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure113Long-term debt, Q2 FY2024, at 2024-06-30$113.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure112Long-term debt, Q3 FY2024, at 2024-09-30$112.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure157Long-term debt, FY2024, at 2024-12-31$157.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure157Long-term debt, Q1 FY2025, at 2025-03-31$156.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure157Long-term debt, Q2 FY2025, at 2025-06-30$157.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure157Long-term debt, Q3 FY2025, at 2025-09-30$157.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure157Long-term debt, FY2025, at 2025-12-31$157.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure221Long-term debt, Q1 FY2026, at 2026-03-31$221.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure222Long-term debt, Q2 FY2026, at 2026-06-30$221.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure
Current portion of debt$mnot reported1.3Current portion of debt, FY2023, at 2023-12-31$1.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-02-25, accession 0000950170-25-026066.Report this figure3.1Current portion of debt, Q1 FY2024, at 2024-03-31$3.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure4.7Current portion of debt, Q2 FY2024, at 2024-06-30$4.7m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure6.3Current portion of debt, Q3 FY2024, at 2024-09-30$6.3m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figurenot reportednot reportednot reported0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figurenot reportednot reported
Shareholders' equity$m615Shareholders' equity, Q3 FY2023, at 2023-09-30$615.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure599Shareholders' equity, FY2023, at 2023-12-31$598.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001193125-26-065189.Report this figure570Shareholders' equity, Q1 FY2024, at 2024-03-31$570.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure546Shareholders' equity, Q2 FY2024, at 2024-06-30$546.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure526Shareholders' equity, Q3 FY2024, at 2024-09-30$525.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure503Shareholders' equity, FY2024, at 2024-12-31$503.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure458Shareholders' equity, Q1 FY2025, at 2025-03-31$458.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure458Shareholders' equity, Q2 FY2025, at 2025-06-30$458.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure442Shareholders' equity, Q3 FY2025, at 2025-09-30$442.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure450Shareholders' equity, FY2025, at 2025-12-31$450.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure435Shareholders' equity, Q1 FY2026, at 2026-03-31$435.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure429Shareholders' equity, Q2 FY2026, at 2026-06-30$429.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure

Cash flow

Operating cash flow−$6.2m, Q2 FY2026
Capital expenditure$12.6m, Q2 FY2026
Orthofix Medical Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m0.5Operating cash flow, Q3 FY2023, three months to 2023-09-30$477.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-122782. Derived: 9-month figure less the 6-month figure.Report this figure(6.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(18.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure9.0Operating cash flow, Q2 FY2024, three months to 2024-06-30$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000950170-25-102384. Derived: 6-month figure less the 3-month figure.Report this figure11.7Operating cash flow, Q3 FY2024, three months to 2024-09-30$11.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263670. Derived: 9-month figure less the 6-month figure.Report this figure23.7Operating cash flow, Q4 FY2024, three months to 2024-12-31$23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(18.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$18.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure11.6Operating cash flow, Q2 FY2025, three months to 2025-06-30$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333822. Derived: 6-month figure less the 3-month figure.Report this figure12.4Operating cash flow, Q3 FY2025, three months to 2025-09-30$12.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-263670. Derived: 9-month figure less the 6-month figure.Report this figure27.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$27.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure(17.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$17.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure(6.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-333822. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m21.9Capital expenditure, Q3 FY2023, three months to 2023-09-30$21.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122782. Derived: 9-month figure less the 6-month figure.Report this figure14.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$14.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-05, accession 0000950170-24-025877. Derived: 12-month figure less the 9-month figure.Report this figure10.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$10.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure9.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$9.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-06, accession 0000950170-24-091200. Derived: 6-month figure less the 3-month figure.Report this figure5.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$5.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-122782. Derived: 9-month figure less the 6-month figure.Report this figure9.7Capital expenditure, Q4 FY2024, three months to 2024-12-31$9.7m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure6.7Capital expenditure, Q1 FY2025, three months to 2025-03-31$6.7m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure7.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$7.1m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-05, accession 0001193125-26-333822. Derived: 6-month figure less the 3-month figure.Report this figure9.9Capital expenditure, Q3 FY2025, three months to 2025-09-30$9.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-04, accession 0001193125-25-263670. Derived: 9-month figure less the 6-month figure.Report this figure10.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-02-24, accession 0001193125-26-065189. Derived: 12-month figure less the 9-month figure.Report this figure10.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$10.7m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure12.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$12.6m. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-05, accession 0001193125-26-333822. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)40.91m, Q2 FY2026
Orthofix Medical Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3020,091 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0000950170-23-061148.Report this figure0.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3135,734 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-053966.Report this figure0.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3036,762 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091200.Report this figure37.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3037,249,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-122782.Report this figure37.7Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3137,741,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-063956.Report this figure38.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3038,020,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000950170-25-102384.Report this figure38.5Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3038,488,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure39.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3139,188,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure39.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3039,501,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure39.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3039,766,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-263670.Report this figure40.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3140,450,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-205003.Report this figure40.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3040,906,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure

Shares outstanding: 40.73mShares outstanding, period not labelled, at 2026-07-3140,732,608 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-333822.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.